flash-tech
automated-news
Adial Pharmaceuticals acquires Azora Therapeutics, secures up to $64M financing
From scams to deepfakes, AI use in Asia creates new cyberthreats
automated-news
The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,
From Trump to Sam Altman, the idea is catching on. Does it make sense?
automated-news
Retail traders’ infatuation with high-flying computer memory and storage companies is fading now that the next big thing — SpaceX’s initial public offering — is on the way.
U.S. stocks were mostly lower, with the Nasdaq leading declines as makers of AI infrastructure suffered steep falls, many in the double digits. Nvidia was down 16%.
OpenAI is reportedly mulling drastic price cuts to its AI models, as it looks to woo consumers from rival AI company Anthropic, the WSJ reported on Wednesday.
AI company says ChatGPT accounts sought to 'exploit and amplify existing public concerns' about energy prices.
OpenAI considers drastic token price cuts to counter Anthropic: WSJ
India is in an 'Opportunity Kaal', not an AI drought, and that companies using AI aggressively will leave rivals behind within five years, says Hiren Ved, Director and CIO of Alchemy Capital Management. The AI adoption is creating a significant divide between leading firms and those lagging behind.